Pharmaceutical composition for preventing and treating cerebral apoplexy
A composition and stroke technology, applied in the directions of drug combinations, active ingredients of hydroxyl compounds, pharmaceutical formulations, etc., can solve the problems of difficult quality control and standardized production, complex composition, poor safety, etc., and achieve convenient standardized production and controllable quality. , the effect of reducing the degree of edema
Active Publication Date: 2021-12-24
GUANGZHOU BAIYUNSHAN PHARMA HLDG CO LTD BAIYUNSHAN PHARMA GENERAL FACTORY
View PDF2 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, these pharmaceutical compositions often have single efficacy, complex composition, or poor safety, and lack strict and systematic pharmacodynamic experiments that meet the requirements of modern pharmacology, making it difficult to carry out strict quality control and standardized production
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Example Embodiment
[0028] Example 1
[0029] Test drug of the present embodiment is illustrated by the following experimental parts by weight of components:
[0030]
[0031]
Example Embodiment
[0032] Example 2
[0033] Test drug of the present embodiment is illustrated by the following experimental parts by weight of components:
[0034]
Example Embodiment
[0035] Example 3
[0036] Test drug of the present embodiment is illustrated by the following experimental parts by weight of components:
[0037]
[0038]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The invention relates to a pharmaceutical composition for preventing and treating cerebral apoplexy. The composition comprises the following components of ginseng, radix aconiti carmichaeli, lucid ganoderma, safflower carthamus, artificial musk, bear gall, pearl, venenum bufonis, borneol and calculus bovis. The composition can obviously improve neurological impairment, relieve the degree of encephaledema and reduce the area of cerebral infarction, and the effect is possibly related to the medicine for relieving oxidative stress and protecting brain tissues from being damaged by oxygen free radicals.
Description
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more Owner GUANGZHOU BAIYUNSHAN PHARMA HLDG CO LTD BAIYUNSHAN PHARMA GENERAL FACTORY
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap